1643 — Modern Chinese Medicine Co Cashflow Statement
0.000.00%
- HK$240.00m
- -HK$67.49m
- CNY344.08m
- 61
- 84
- 30
- 63
Annual cashflow statement for Modern Chinese Medicine Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 65.3 | 90.5 | 114 | 124 | 68.3 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -0.177 | 1.95 | -0.788 | 5.44 | 0.385 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -26.4 | -51.5 | -58.6 | -9.67 | -66.7 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 40.2 | 42.8 | 57.6 | 126 | 8.48 |
Capital Expenditures | -2.62 | -0.544 | -70.5 | -11.7 | -5.1 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 1.41 | 0.136 | 0.421 | 0.675 | 0.906 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -1.21 | -0.408 | -70 | -11 | -4.19 |
Financing Cash Flow Items | -97.9 | -4.72 | -26.7 | -0.014 | -0.005 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -92.9 | -5.05 | 116 | -8.73 | -0.326 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -54 | 37.3 | 103 | 106 | 4.01 |